New
Psyomics
The AI engine Fit Assessment
BetaThe company will be attending the 2024 Health Tech Forward Event
Blurb
PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.
HQ Location
United Kingdom
Founded
2015
Employees
11 - 50
Total funding raised
$11.52M
Last Funding Event
Venture - Series Unknown, $5.11M, June 5, 2024
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Developer of web-based assessment triage designed for diagnostic and pathway prediction for mental health conditions. The company's services combine digital profiling with the latest advances in biological research to enhance diagnostic accuracy and help primary care practitioners efficiently manage their patient's mental health needs by digitally mirroring a psychiatric assessment at the first point of contact, enabling patients to get enhanced recovery from mental health disorders.